BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 543572)

  • 1. Retrospective DNA analyses in cervical dysplasia as related to neoplastic progression or regression.
    Nasiell K; Auer G; Nasiell M; Zetterberg A
    Anal Quant Cytol; 1979; 1(2):103-6. PubMed ID: 543572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation patterns of cervical cells as visualized in Leiden liquid cytology slides.
    Luzzatto L; van Haaften C; Boon ME
    Diagn Cytopathol; 2004 Jul; 31(1):5-9. PubMed ID: 15236256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNA content and prognosis in atypical cervix epithelium].
    Bergleiter R
    Zentralbl Gynakol; 1986; 108(19):1164-9. PubMed ID: 3811665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic and cytochemical analysis in the differential diagnosis of cervical epithelial lesions.
    Nasiell K; Näslund I; Auer G
    Anal Quant Cytol; 1984 Sep; 6(3):196-200. PubMed ID: 6508037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphotometric nuclear DNA analysis in cervical dysplasia of the uterine cervix: its relation to the progression to malignancy and regression to normalcy.
    Kashyap V; Das DK; Luthra UK
    Neoplasma; 1990; 37(5):497-500. PubMed ID: 2234211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
    Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
    Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of severe dysplasia and carcinoma in situ detected by directed biopsy].
    Milojković M; Makarović Z; Pajtler M
    Jugosl Ginekol Perinatol; 1989; 29(5-6):198-200. PubMed ID: 2640269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytomorphologic and morphometric characteristics of the endocervical epithelium during malignant degeneration].
    Novik VI; Agroskin LS; Solov'eva LV
    Vopr Onkol; 1989; 35(6):715-21. PubMed ID: 2750084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apoptosis and cell growth fraction in normal, dysplastic and neoplastic squamous epithelium of uterine cervix].
    Furuya H; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):141-8. PubMed ID: 7706854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exfoliative immunocytology of cervical carcinoma.
    Efthymiou CJ; Smulewicz JJ
    Arch Pathol Lab Med; 1977 Nov; 101(11):575-8. PubMed ID: 334107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
    Nishiya I; Ishizaki Y; Sasaki M
    Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papanicolaou test and enzyme-linked in-situ hybridization. A combined diagnostic system for papilloma virus infections with high prognostic value.
    Schön HJ; Czerwenka KF; Schurz B; Kramar R; Kubista E
    Eur J Clin Chem Clin Biochem; 1991 Feb; 29(2):131-8. PubMed ID: 1646654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LA-1 oncogene. A possible new prognostic index for evaluating cervical squamous intraepithelial lesions.
    Sainz de la Cuesta R; Reed TP; Brothman JC; Dubin NH
    J Reprod Med; 1993 Mar; 38(3):173-8. PubMed ID: 8487232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
    Pairwuti S
    Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colposcopic management of abnormal cervical cytology in pregnancy.
    LaPolla JP; O'Neill C; Wetrich D
    J Reprod Med; 1988 Mar; 33(3):301-6. PubMed ID: 3361522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology and DNA content of cultures from normal and dysplastic epithelium, carcinoma in situ and carcinomas of the cervix uteri (author's transl)].
    Ebeling K; Krug H; Bilek K
    Arch Geschwulstforsch; 1978; 48(1):17-34. PubMed ID: 655777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of phenotypic cytologic characteristics in early dysplastic cervical lesions.
    Schlaen I; Gonzalez Garcia MR; Weismann EA
    Acta Cytol; 1988; 32(3):298-302. PubMed ID: 3287818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.